(Theme 2) The role of antibody in COVID-19 disease: distinguishing disease enhancing and prtective immune responses.

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-354

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Michael Levin
  • Research Location

    United Kingdom
  • Lead Research Institution

    Francis Crick Institute
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The emergence of rare but debilitating conditions associated with SARS-CoV-2 - including Paediatric Inflammatory Multisystem Syndrome (PIMS) or Kawasaki disease (KD) - has raised concern that antibodies may enhance disease. In this project, researchers aim to assess how cross-reactive antibodies against other coronaviruses cause severe disease, how do antibody responses differ between patients with asymptomatic/mild infections and severe disease and how antibodies influence the rest of the immune response.